5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes. Nitric oxide (NO) donors also increase mitochondrial biogenesis. more...
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes. Nitric oxide (NO) donors also increase mitochondrial biogenesis. Since neuronal and endothelial NO synthase (NOS) are calcium-dependent and are also phosphorylated by AMPK, we hypothesized that NOS inhibition would attenuate the activation of mitochondrial biogenesis in response to AICAR and caffeine. L6 myotubes were either not treated (control) or were exposed acutely or for 5 hours/day over 5 days to 100muM of N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor); 100muM S-nitroso-N-acetylpenicillamine (SNAP, NO donor) +/- 100muM L-NAME; 2mM AICAR +/- 100muM L-NAME; or 5mM caffeine +/- 100muM L-NAME (n=12/treatment). Acute AICAR administration increased (P<0.05) phospho- (P-)AMPK, but also increased P-CaMK, with resultant chronic increases in peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1alpha (PGC-1alpha), cytochrome oxidase (COX) I and COXIV protein expression compared with control cells. NOS inhibition, which had no effect on AICAR-stimulated P-AMPK, surprisingly increased P-CaMK and attenuated the AICAR induced increases in COXI and COXIV protein. Caffeine administration, which increased P-CaMK without affecting P-AMPK, increased COXI, COXIV, PGC-1alpha and CS activity. NOS inhibition, surprisingly, greatly attenuated the effect of caffeine on P-CaMK and attenuated the increases in COXI and COXIV protein. SNAP increased all markers of mitochondrial biogenesis and it also increased P-AMPK and P-CaMK. In conclusion, AICAR and caffeine increase mitochondrial biogenesis in L6 myotubes, at least in part, via interactions with NOS. Key words: AMPK, calcium, mitochondria, nitric oxide synthase. less...
Central role of nitric oxide synthase in AICAR and caffeine induced mitochondrial biogenesis in L6 myocytes.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | - Caffeine
- Aicar
- Nitric Oxide
| | - Protein/Gene relationships
|
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
Since neuronal and endothelial NO synthase (NOS) are calcium-dependent and are also phosphorylated by AMPK, we hypothesized that NOS inhibition would attenuate the activation of mitochondrial biogenesis in response to AICAR and caffeine.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
L6 myotubes were either not treated (control) or were exposed acutely or for 5 hours/day over 5 days to 100muM of N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor); 100muM S-nitroso-N-acetylpenicillamine (SNAP, NO donor) +/- 100muM L-NAME; 2mM AICAR +/- 100muM L-NAME; or 5mM caffeine +/- 100muM L-NAME (n=12/treatment).
| Gene | Disease | Drug | Processes | Categories |
|---|
| | - Caffeine
- Aicar
- Nitroarginine
| | |
Acute AICAR administration increased (P<0.05) phospho- (P-)AMPK, but also increased P-CaMK, with resultant chronic increases in peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1alpha (PGC-1alpha), cytochrome oxidase (COX) I and COXIV protein expression compared with control cells.
| Gene | Disease | Drug | Processes | Categories |
|---|
- PRGC1_HUMAN
- COX41_HUMAN
- PUR9_HUMAN
- AAPK2_HUMAN
| | | | - Protein/Gene relationships
|
NOS inhibition, which had no effect on AICAR-stimulated P-AMPK, surprisingly increased P-CaMK and attenuated the AICAR induced increases in COXI and COXIV protein.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
Caffeine administration, which increased P-CaMK without affecting P-AMPK, increased COXI, COXIV, PGC-1alpha and CS activity.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
NOS inhibition, surprisingly, greatly attenuated the effect of caffeine on P-CaMK and attenuated the increases in COXI and COXIV protein.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
In conclusion, AICAR and caffeine increase mitochondrial biogenesis in L6 myotubes, at least in part, via interactions with NOS.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|
Key words: AMPK, calcium, mitochondria, nitric oxide synthase.
| Gene | Disease | Drug | Processes | Categories |
|---|
| | | | - Protein/Gene relationships
|